BE720801A - - Google Patents

Info

Publication number
BE720801A
BE720801A BE720801DA BE720801A BE 720801 A BE720801 A BE 720801A BE 720801D A BE720801D A BE 720801DA BE 720801 A BE720801 A BE 720801A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE720801A publication Critical patent/BE720801A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
BE720801D 1967-09-15 1968-09-13 BE720801A (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEF0053504 1967-09-15
LU57488 1968-12-06
US21852472A 1972-01-17 1972-01-17

Publications (1)

Publication Number Publication Date
BE720801A true BE720801A (xx) 1969-03-13

Family

ID=27210542

Family Applications (1)

Application Number Title Priority Date Filing Date
BE720801D BE720801A (xx) 1967-09-15 1968-09-13

Country Status (5)

Country Link
US (16) US3660577A (xx)
BE (1) BE720801A (xx)
FR (2) FR1597530A (xx)
GB (1) GB1170188A (xx)
LU (1) LU57488A1 (xx)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2013409A1 (xx) * 1968-07-20 1970-04-03 Bayer Ag
FR2024563A1 (xx) * 1968-11-29 1970-08-28 Bayer Ag
DE2213863A1 (de) * 1972-03-22 1973-10-04 Bayer Ag Disubstituierte triphenylmethylimidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2009020B2 (de) * 1970-02-26 1979-01-11 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von N-U,l,l-trisubstituierten)-Methylazolen

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980780A (en) * 1970-03-23 1976-09-14 Bayer Aktiengesellschaft N-Methyl-imidazole derivatives for treating mycotic infections
US3764609A (en) * 1970-06-22 1973-10-09 Koninklijke Pharma Fab Nv 1 (dibenzo {8 4,d{9 {0 cyclohepten-5-yl), 1-(dibenzo {8 a,d{9 {0 cycloheptan-5-yl) and 1-(dibenzo {8 a,d{9 {0 cyclooctanyl)imidazoles
DE2037610A1 (de) * 1970-07-29 1972-02-03 Bayer Ag Neue alpha-substituierte Benzyl-azole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US4117142A (en) * 1972-03-22 1978-09-26 Bayer Aktiengesellschaft Disubstituted triphenylmethylmidazoles for treating mycotic infections
DE2314985A1 (de) * 1973-03-26 1974-10-17 Hoechst Ag 1-(imidazol-1-yl)-isochinoline und verfahren zu ihrer herstellung
JPS6048486B2 (ja) * 1976-01-01 1985-10-28 木場 常義 抗リウマチ剤
FR2387658A1 (fr) * 1977-03-25 1978-11-17 Ciba Geigy Ag Procede pour combattre les microorganismes
US4267169A (en) * 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
US4216333A (en) * 1978-10-30 1980-08-05 Sumitomo Chemical Company, Limited Process for preparing N-tritylimidazole compounds
US4439441A (en) * 1979-01-11 1984-03-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
JPS5692887A (en) * 1979-12-05 1981-07-27 Sumitomo Chem Co Ltd N-substituted imidazole derivative
JPS58150566A (ja) * 1982-03-03 1983-09-07 Yoshitomi Pharmaceut Ind Ltd 新規イミダゾ−ル誘導体
US4755526A (en) * 1984-06-18 1988-07-05 Eli Lilly And Company Method of inhibiting aromatase
US4775678A (en) * 1984-10-01 1988-10-04 Schering Corporation Clotrimazole cream
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
EP0352352B1 (en) * 1988-07-28 1991-10-16 J. URIACH & CIA. S.A. 1-[(2-Fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-imidazole
US5177099A (en) * 1989-04-10 1993-01-05 Sociedad Espanola De Especialidades Farmaco-Terapeuticas S.A. Dichloro-substituted imidazole derivatives as antifungal agents
CA2035758C (en) * 1990-03-06 2002-04-02 Yataka Murata Antimycotic external imidazole preparations
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions
US6177427B1 (en) * 1994-06-28 2001-01-23 Alcon Laboratories, Inc. Treatment of glaucoma and ocular hypertension
EP1052990A2 (en) * 1997-11-14 2000-11-22 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
US6080744A (en) * 1999-02-10 2000-06-27 Ayon-Covarrubias; Blas Topical antifungal treatment
US6450515B1 (en) * 2000-10-10 2002-09-17 James F. Guth Clip-on wheels for pallets or other structures with runners
US20060211632A1 (en) * 2005-03-17 2006-09-21 Bachmann Kenneth A PXR agonists for cardiovascular disease
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
BRPI0904249B1 (pt) 2009-08-28 2018-03-06 Biolab Sanus Farmacêutica Ltda. Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica
AU2010300550B2 (en) 2009-10-01 2014-10-30 Adare Pharmaceuticals, Inc. Orally administered corticosteroid compositions
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
JP6723698B2 (ja) * 2015-07-23 2020-07-15 東京応化工業株式会社 微粒子含有組成物
US20170112824A1 (en) * 2015-10-23 2017-04-27 Wright State University Combination therapies for the treatment of fungal infections
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
EP3558304A2 (en) 2016-12-23 2019-10-30 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitors of cytochrome p450 family 7 subfamily b member 1 (cyp7b1) for use in treating diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321366A (en) * 1965-11-15 1967-05-23 Dow Chemical Co Fungicidal methods and compositions

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2013409A1 (xx) * 1968-07-20 1970-04-03 Bayer Ag
FR2024563A1 (xx) * 1968-11-29 1970-08-28 Bayer Ag
DE2009020B2 (de) * 1970-02-26 1979-01-11 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von N-U,l,l-trisubstituierten)-Methylazolen
DE2009020C3 (de) * 1970-02-26 1979-09-13 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von N-(l,l,l-trisubstituierten)-Methylazolen
DE2213863A1 (de) * 1972-03-22 1973-10-04 Bayer Ag Disubstituierte triphenylmethylimidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
US3839573A (en) 1974-10-01
US3720770A (en) 1973-03-13
GB1170188A (en) 1969-11-12
DE1617481B2 (de) 1975-07-24
US3711500A (en) 1973-01-16
FR1597530A (xx) 1970-06-29
DE1617481A1 (de) 1971-04-08
US3711501A (en) 1973-01-16
US3717657A (en) 1973-02-20
FR8112M (xx) 1970-07-27
US3657442A (en) 1972-04-18
US3657445A (en) 1972-04-18
US3655900A (en) 1972-04-11
US3660576A (en) 1972-05-02
US3711498A (en) 1973-01-16
US3711499A (en) 1973-01-16
US3660577A (en) 1972-05-02
US3658956A (en) 1972-04-25
LU57488A1 (xx) 1969-03-13
US3767668A (en) 1973-10-23
US3705172A (en) 1972-12-05
US3655899A (en) 1972-04-11

Similar Documents

Publication Publication Date Title
AU425114B2 (xx)
FR8112M (xx)
AU416737B2 (xx)
AU342066A (xx)
AU3189468A (xx)
AU610966A (xx)
BE426053A (xx)
BE609934A (xx)
AU34866A (xx)
BE692198A (xx)
BE609869A (xx)
BE514578A (xx)
BE692553A (xx)
NL6813149A (xx)
BE711466A (xx)
BE711401A (xx)
BE711133A (xx)
BE509738A (xx)
BE483855A (xx)
BE710793A (xx)
BE710712A (xx)
BE710100A (xx)
BE710026A (xx)
BE709905A (xx)
BE477645A (xx)

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARBENFABRIKEN BAYER A.G.

Effective date: 19840913